![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
LIFESTYLE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
|
|
|
Download the PDF here
EASL 2019 April 10-14 Vienna
Shira Zelber-Sagi R.D. Ph.D
Dept. of Gastroenterology
Tel Aviv Medical Center
School of Public Health,
Haifa University
Israel
Triple Hit for the Liver: Poor Diet, Sedentary Behavior, Low Physical Activity. HIV+ Have Increased Risk For Fatty Liver Disease (NAFLD)
EASL: The Increasing Importance of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Human Immunodeficiency Virus (HIV) - (04/18/19) NAFLD is increasing as an important cause of LD and reason for liver mortality in this group of patients: Between 2006 and 2016, rates for viral hepatitis decreased from 27.75 to 24.17 (p = .009) while, the rate for NAFLD in HIV (+) Medicare recipients doubled from 5.32 to 11.62 per 100, 000 (p < .001)., During the study period, the death rates related to viral hepatitis in HIV (+) Medicare recipients decreased from 3.78 to 2.58 (p = .006), while the mortality for NAFLD in this group increased from 0.18 to 0.80 for NAFLD (p = .041).
FATTY LIVER in HIV+, alcohol, 50% have NAFLD, 27% Liver Fibrosis - The prevalence of liver fibrosis in HIV infected patients with abnormal liver function tests - (04/23/19)
14/21 (66.7%) patients undergoing liver biopsy had a clinical diagnosis of NAFLD: 71.4% (10/14) had steatohepatitis on liver biopsy and were at risk of progression to liver cirrhosis; 66.7% (4/6) of patients with a normal FibroScan® score had steatohepatitis on liver biopsy; 71.4% (10/14) had steatohepatitis on liver biopsy and were at risk of progression to liver cirrhosis"
EASL: APPLICATION OF GUIDELINES FOR FATTY LIVER IN TWO PROSPECTIVE COHORTS OF HIV+ PATIENTS: 32% have NAFLD; among those without NAFLD 18% with elevated ALT - (04/22/19)
EASL: Increasing Number of Metabolic Co-Morbidities are Associated with Higher Risk of Advanced Fibrosis in Patients with Nonalcoholic Steatohepatitis - (04/22/19)
EASL: The socio-economic burden of NASH in Europe and the United States: the GAIN study - (04/26/19)
EASL: Liver Disease in UK General Population: Fatty & Alcohol Liver Disease; Lack of Awareness: 4% aware; High Rate of Risk Factors: 89% - (04/23/19)
![0430191](../images/043019/043019-4/0430191.gif)
![0430192](../images/043019/043019-4/0430192.gif)
![0430193](../images/043019/043019-4/0430193.gif)
![0430194](../images/043019/043019-4/0430194.gif)
![0430195](../images/043019/043019-4/0430195.gif)
EASL: High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance - (04/23/19)
EASL: A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases - (04/23/19)
![0430196](../images/043019/043019-4/0430196.gif)
![0430197](../images/043019/043019-4/0430197.gif)
![0430198](../images/043019/043019-4/0430198.gif)
![0430199](../images/043019/043019-4/0430199.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|